Oral Intake of Inosine 5′-Monophosphate in Mice Promotes the Absorption of Exogenous Fatty Acids and Their Conversion into Triglycerides though Enhancing the Phosphorylation of Adenosine 5′-Monophosphate-Activated Protein Kinase in the Liver, Leading to Lipohyperplasia
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914588 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Plant Development, Chinese Academy of Medical Science & Peking Union Medical College, Malianwa North Road No. 151, Haidian Dis…. Hauptthemen laut MEDLINE: Protein Kinases, Fatty Acids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Inosine 5′-monophoaphate (IMP) is a food additive that promotes serious lipohyperplasia in the liver of C57/KsJ-db/db (db/db) mice. Thus, IMP taken orally by healthy mice might also damage their health. To date, how IMP affects health after being taken by healthy animals is still unclear. Therefore, we investigated the health of C57BL/6J mice affected by IMP intake. Our data revealed that C57BL/6J mice administered 255 μM IMP daily via oral gavage for 4 months caused hyperlipidemia and an increase in body fat rate. The expressions of acetyl-CoA carboxylase 1 (ACC1) and phosphorylated acetyl-CoA carboxylase 2 (ACC2) in hepatocytes increased though the administration of IMP, promoting the phosphorylation of adenosine 5′-monophosphate-activated protein kinase (AMPK). The conversion of acetyl-CoA into triglycerides (TGs) was promoted by ACC1. These TGs were transported from the hepatocytes to avoid the development of non-alcoholic fatty liver disease (NAFLD), causing a deficiency of acetyl-CoA in the liver, and then, the increased phosphorylated ACC2 promoted the cytoplasm fatty acids entering the mitochondria and conversion into acetyl-CoA through the fatty acid β-oxidation pathway, causing a deficiency in fatty acids. Therefore, the liver showed enhanced absorption of exogenous fatty acids, which were converted into TGs, causing lipohyperplasia. In conclusion, an excessive IMP intake promotes metabolic dysfunction in adipose tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medicinal Plant Development, Chinese Academy of Medical Science & Peking Union Medical College, Malianwa North Road No. 151, Haidian District, Beijing 100193, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, B., Xu, Y., Liu, J., Wu, C., Zhao, X., Zhou, L., & Xie, Y. (2023). Oral Intake of Inosine 5′-Monophosphate in Mice Promotes the Absorption of Exogenous Fatty Acids and Their Conversion into Triglycerides though Enhancing the Phosphorylation of Adenosine 5′-Monophosphate-Activated Protein Kinase in the Liver, Leading to Lipohyperplasia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914588
Vancouver
Zhang B, Xu Y, Liu J, Wu C, Zhao X, Zhou L, et al. Oral Intake of Inosine 5′-Monophosphate in Mice Promotes the Absorption of Exogenous Fatty Acids and Their Conversion into Triglycerides though Enhancing the Phosphorylation of Adenosine 5′-Monophosphate-Activated Protein Kinase in the Liver, Leading to Lipohyperplasia. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914588
BibTeX
@article{Zhang2023,
author = {Zhang, Bin and Xu, Yang and Liu, Jinyan and Wu, Chongming and Zhao, Xiaohong and Zhou, Lidong and Xie, Yong},
title = {Oral Intake of Inosine 5′-Monophosphate in Mice Promotes the Absorption of Exogenous Fatty Acids and Their Conversion into Triglycerides though Enhancing the Phosphorylation of Adenosine 5′-Monophosphate-Activated Protein Kinase in the Liver, Leading to Lipohyperplasia},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914588}
}
EUVIMED